Gene therapy for chronic granulomatous disease and leukocyte adhesion deficiency

International Journal of Pediatric Hematology/Oncology

Volumn 7, Issue 5-6, 2001, Pages 359-372

  Goebel, W S ^a   Kume, A ^a   Dinauer, M C ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic granulomatous disease (CGD); Gene therapy; Leukocyte adhesion deficiency type 1 (LAD 1)

Indexed keywords

BETA2 INTEGRIN; CD18 ANTIGEN; COMPLEMENT COMPONENT C3; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RETROVIRUS VECTOR;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLUS; BURKHOLDERIA CEPACIA; CELL MIGRATION; CHRONIC GRANULOMATOUS DISEASE; CONTROLLED STUDY; GENE DISRUPTION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; INFECTION RESISTANCE; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHESION DEFICIENCY; MORBIDITY; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; RECURRENT INFECTION; STAPHYLOCOCCUS AUREUS; VASCULAR ENDOTHELIUM;

EID: 0035670208     PISSN: 10702903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (97)

1. Genetic disorders of phagocyte function
2. The phagocyte system and disorders of granulopoiesis and granulocyte function
3. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease
4. NADPH oxidase: An update
5. Leukocyte adhesion deficiency: An inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins
6. The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: Their quantitative definition and relation to leukocyte dysfunction and clinical features
7. Marrow transplantation in chronic granulomatous disease: An update, with 6-year follow-up
8. Chronic granulomatous disease 100% corrected by displacement bone marrow transplantation from a volunteer unrelated donor
9. Bone marrow transplantation in chronic granulomatous disease
10. Successful bone marrow transplantation in a child with X-linked chronic granulomatous disease
11. Treatment of genetic defects in hematopoietic cell function by gene transfer
12. Gene therapy for congenital immunodeficiency diseases
13. Introduction of new genetic material into pluripotent stem cells of the mouse
14. Gene transfer to hematopoietic stem cells: Implications for gene therapy of human disease
15. Hematopoietic stem cell gene therapy: A current overview
16. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor
17. Bone Marrow Extracellular Matrix Molecules Improve Gene Transfer in to Human Hematopoietic Cells via Retroviral Vectors
18. The use of cytokines active on primitive hematopoietic cells and stromal or fibronectin support during transduction improves stable retroviral gene transfer into primate CD34+ hematopoietic cells to clinically relevant levels
19. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells
20. In vivo gene therapy and stable transduction of nondividing cells by a lentiviral vector
21. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
22. Efficient transduction of nondividing human cells by feline immuno-deficiency virus lentiviral vectors
23. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors
24. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors
25. X-linked inheritance in females with chronic granulomatous disease
26. Recurrent severe infection in a girl with apparently variable expression of mosaicism for chronic granulomatous disease
27. 91-phox Chronic Granulomatous Disease (CGD): Clinical and potential therapeutic implications of extreme unbalanced x chromosome inactivation
28. Enhanced host defense after gene transfer in the murine p47phox-deficient model of chronic granulomatous disease
29. Recent advances in chronic chronic granulomatous disease
30. Prognosis of chronic granulomatous disease
31. Molecular basis of the autosomal recessive forms of chronic granulomatous disease
32. The NADPH oxidase and chronic granulomatous disease
33. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus
34. Continuous therapy with sulfamethoxazole-thrimethoprim in patients with chronic granulomatous disease
35. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease
36. Corticosteroids in treatment of obstructive lesions of chronic granulomatous disease
37. Clinical differences in chronic granulomatous disease in patients with cytochrome b-negative or cytochrome b positive neutrophils
38. Mouse Model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production
39. phox mouse knock-out model of chronic granulomatous disease
40. Use of an X-linked human neutrophil marker to estimate timing of lyonization and size of the dividing stem cell pool
41. A study of 25 patients with chronic granulomatous disease: A new classification by correlating respiratory burst, cytochrome b and flavoprotein
42. Chronic granulomatous disease in an elderly man: An X-linked cytochrome b positive variant
43. Chronic granulomatous disease with partial deficiency of cytochrome b558 and incomplete respiratory burst: Variants of the X-linked, cytochrome b558-negative form of the disease
44. A new X-linked variant of chronic granulomatous disease characterized by the existence of a normal clone of respiratory burst-competent phagocytic cells
45. Molecular Analysis in Three Cases of X91-variant chronic granulomatous disease
46. In vitromolecular reconstition of the respiratory burst in B lymphoblasts from p47-phox-deficient chronic granulomatous disease
47. phox cDNA
48. X-linked chronic granulomatous disease: Correction of NADPH oxidase defect by retrovirus-mediated expression of gp91-phox
49. phox-deficient chronic granulomatous disease
50. 558 defective forms of chronic granulomatous disease
51. Partial reconstitution of the respiratory burst oxidase in lymphoblastoid B cell lines lacking p67-phox after transfection with an expression vector containing wild-type and mutant p67-phox cDNAs: Deletions of the terminal residues of p67-phox are not required for activity
52. phox
53. Retrovirus-mediated reconstitution of respiratory burst activity in X-linked chronic granulomatous disease cells
54. phox
55. Efficient retroviral transduction of human bone marrow progenitor and long-term culture-initiating cells: Partial reconstitution of cells from patients with X-linked chronic granulomatous disease by gp91-phox expression
56. Genetic correlation of p67phox deficient cronic granulomatous disease using peripheral blood progenitor cells as a target for retrovirus mediated gene transfer
57. Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells
58. Retroviral-mediated gene transfer of gp91phox into bone marrow cells rescues in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease
59. Long-term correction of phagocyte NADPH oxidase activity by retroviral-mediated gene transfer in murine X-linked chronic granulomatous disease
60. Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells
61. Versatile retroviral vectors for potential use in gene therapy
62. Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease
63. phox transduced CD34+ cells
64. In vivo selection of retrovirally transduced hematopoietic stem cells
65. Transgenic mice expressing the tyr22 variant of murine DHFR: Protection of transgenic marrow transplant recipients from lethal doses of methotrexate
66. Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice
67. Nonmyeloablative, T-cell depleted allogeneic peripheral blood stem cell (PBSC) transplantation for patients with chronic granulomatous disease
68. Leukocyte adhesion deficiency syndrome: Insights into the molecular basis of leukocyte emigration
69. Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor
70. Leukocyte-endothelial adhesion molecules
71. Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins
72. A novel leukocyte adhesion deficiency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1
73. Results of allogeneic bone marrow transplantation in patients with leukocyte adhesion deficiency
74. Successful HLA-identical sibling cord blood transplantation in a 6-year-old boy with leukocyte adhesion deficiency syndrome
75. Brief report: Recurrent severe infections caused by a novel leukocyte adhesion deficiency
76. Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism
77. Leukocyte adhesion deficiency type II: Long-term follow-up
78. Leukocyte Adhesion Deficiency Type II is a generalized defect of de novo GDP-fucose biosynthesis. Endothelial cell fucosylation is not required for neutrophil rolling on human nonlymphoid endothelium
79. In vivo behavior of neutrophils from two patients with distinct inherited leukocyte adhesion deficiency syndromes
80. Neutrophil adhesion in leukocyte adhesion deficiency syndrome type 2
81. Correction of leukocyte adhesion deficiency type II with oral fucose
82. Of man and mouse: Leukocyte and endothelial adhesion molecule deficiencies
83. Gene targeting yields a CD18-mutant mouse for study of inflammation
84. Neutrophil emigration in the skin, lungs, and peritoneum: Different requirements for CDH/CD18 revealed by CD18-deficient mice
85. Spontaneous skin ulceration and defective T cell function in CD18 null mice
86. LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor
87. LFA-1 is sufficient in mediating neutrophil emigration in Mac-1-deficient mice
88. An in vivo animal model of gene therapy for leukocyte adhesion deficiency
89. Expression of retroviral transduced human CD18 in murine cells: An in vitro model of gene therapy for leukocyte adhesion deficiency
90. Transfection of cells from patients with leukocyte adhesion deficiency with an integrin beta subunit (CD18) restores lymphocyte function-associated antigen-1 expression and function
91. Retroviral-mediated gene transfer of the leukocyte integrin CD18 subunit
92. Correction of CD18-deficient lymphocytes by retrovirus-mediated gene transfer
93. Improved transfer of the leukocyte integrin CD18 subunit into hematopoietic cell lines by using retroviral vectors having a gibbon ape leukemia virus envelope
94. Expression from leukocyte integrin promoters in retroviral vectors
95. Retroviral-mediated gene expression in human myelomonocytic cells: A comparison of hematopoietic cell promoters to viral promoters
96. Retroviral mediated expression of CD18 in normal and deficient human bone marrow progenitor cells
97. Retroviral-mediated gene transfer of the leukocyte integrin CD18 into peripheral blood CD34+ cells derived from a patient with leukocyte adhesion deficiency type 1